| Literature DB >> 28018852 |
Margit Schönherr1, Hermann Stefan1, Hajo M Hamer1, Karl Rössler2, Michael Buchfelder2, Stefan Rampp2.
Abstract
OBJECTIVE: In this study, we use a novel automated method for localization and quantitative comparison of magnetoencephalographic (MEG) delta activity in patients with and without recurrent seizures after epilepsy surgery as well as healthy controls.Entities:
Keywords: Delta activity; Epilepsy; Persisting seizures; Surgery
Mesh:
Year: 2016 PMID: 28018852 PMCID: PMC5167245 DOI: 10.1016/j.nicl.2016.12.001
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Overview of patients, epilepsy history, and surgery for patients with recurrent seizures (group P) and seizure free patients after epilepsy surgery (group SF). “Age”, “Epilepsy duration” and “years post-OP” are given at the time of the MEG recording for the presented study. In some cases, there was more than one surgical procedure. For each procedure, the time since surgery is listed. MRI findings after first surgery are only mentioned if more than the resection volume of previous surgery was reported. Some of the patients were not operated at our institution; not all information is available in these.
| Patient | Age | Sex | Epilepsy duration (years) | Evidence before first surgery | Location of resection | Histology | Years post-OP | EEG/MRI (after first surgery) |
|---|---|---|---|---|---|---|---|---|
| P1 | 21 | m | 15 | FCD r parietal/occipital | r parietal/occipital | Unclear | 6 | EEG: r frontal, parietal and occipital spikes, l frontal spikes, r parieto-occipital seizures |
| P2 | 15 | f | 5 | FCD | l frontal | FCD 1a | 4.5 | EEG: l frontal spikes, l central seizures, l frontal, central, temporal slowing |
| P3 | 41 | m | 27 | Subependymoma | l temporal | Subependymoma | 5 | EEG: bifrontal spikes and seizures |
| P4 | 31 | m | 25 | FCD | r frontal | Normal | 3.3 | EEG: r fronto-temp. delta-theta; bifrontal spikes |
| P5 | 25 | m | 9 | FCD | l frontal | Normal | 1 | EEG: l fronto-central spikes |
| P6 | 23 | m | 7 | Meningioma | r fronto-central | Meningioma | 8 | EEG: r parietal slowing |
| P7 | 54 | f | 37 | MRI negative | l temporal | Astrogliosis | 10 | EEG: l temp slowing and seizures, bitemporal/parietal spikes |
| P8 | 32 | m | 13 | Astrocytoma | l temporal | Astrocytoma | 19 | EEG: l temp/par/occ slowing |
| P9 | 39 | f | 27 | FCD | r parietal/occipital | FCD | 6 | EEG: r parieto-occipital seizures |
| P10 | 36 | m | 21 | TLE | r temporal | Hippocampal sclerosis | 9 | EEG: bitemporal seizures and slowing |
| P11 | 50 | f | 34 | MRI negative | r temporal | mMCD | 2.5 | EEG: r temp seizures and slowing |
| P12 | 23 | f | 18 | MRI negative | r temporal | FCD | 13 | EEG: bitemporal slowing and sharp waves |
| P13 | 31 | m | 20 | Cystic lesion | r occipital | Unclear | 19 | EEG: r temp spikes and seizures |
| P14 | 44 | f | 30 | TLE | l temporal | Hippocampal sclerosis | 6 | EEG: l temp/par spikes and seizures |
| P15 | 32 | f | 19 | MRI negative | r temporal | Unclear | 13 | EEG: r temp slowing, spikes, seizures |
| SF1 | 31 | f | 2 | Cavernoma | l temporo-mesial | Cavernoma | 1 | EEG: breach rhythm, no spike |
| SF2 | 36 | m | 33 | Hippocampal sclerosis | r temporal | Hippocampal sclerosis | 2 | EEG: breach rhythm, slowing, no spike |
| SF3 | 50 | f | 33 | Hippocampal sclerosis | r temporal | Hippocampal sclerosis | 1 | EEG: breach rhythm, no spike |
| SF4 | 26 | m | 7 | Ganglioglioma/DNET | l temporal | Ganglioglioma | 2.3 | EEG: breach rhythm, slowing, no spike |
| SF5 | 22 | f | 1 | Ganglioglioma | l temporal | Ganglioglioma | 0.5 | EEG: without pathological findings |
| SF6 | 57 | f | 48 | Hippocampal sclerosis | r temporal | Hippocampal sclerosis | 1 | EEG: breach rhythm, slowing, no spike |
| SF7 | 29 | m | 13 | MRI negative | l temporal | Normal | 0.5 | EEG: breach rhythm, slowing, no spike |
| SF8 | 43 | m | 4 | Cavernoma | r temporal | Cavernoma | 0.5 | EEG: without pathological findings |
| SF9 | 54 | m | 6 | Hippocampal sclerosis | l temporal | Hippocampal sclerosis | 0.5 | EEG: breach rhythm, slowing, no spike |
| SF10 | 40 | f | 36 | Hippocampal sclerosis | r temporal | Hippocampal sclerosis | 2 | EEG: breach rhythm, slowing, spike |
m – male, f – female, l – left, r – right, FCD - focal cortical dysplasia, mMCD - mild malformation of cortical development, TLE - temporal lobe epilepsy.
Delta activity in patients with recurrent seizures (group P). Location of the epileptic focus for determination of overlap with delta activity is based on the consensus decision of epilepsy surgery case conferences, which may deviate from spike locations.
| Patient | Maximum z-value | z-Value at spike location | Distance [cm] | Spike frequency (/10 min) | Mono-/multifocal delta distribution | Overlap of delta with focus |
|---|---|---|---|---|---|---|
| P1 | 39.6 | 18.3 | 3.8 | 3 | Mono | Yes |
| P2 | 211.3 | 35.4 | 2.0 | 18 | Mono | Yes |
| P3 | 9.8 | No spikes | – | 0 | Multi | Yes |
| P4 | 33.5 | 6.8 | 1.6 | 8 | Mono | Yes |
| P5 | 44.8 | 29.3 | 1.3 | 12 | Mono | Yes |
| P6 | 37.6 | 14.5 | 9.4 | 2 | Multi | Yes |
| P7 | 7.6 | 0.3 | 8.2 | 4 | Mono | Yes |
| P8 | 157.1 | 64.0 | 4.3 | 7 | Mono | Yes |
| P9 | 5.6 | 4.2 | 0.8 | 20 | Mono | Yes |
| P10 | 8.4 | 3.8 | 1.0 | 2 | Mono | Yes |
| P11 | 29.0 | 9.1 | 2.6 | 1 | Multi | Yes |
| P12 | 146.4 | 50.7 | 1.5 | 20 | Mono | Yes |
| P13 | 34.7 | 26.8 | 0.9 | 76 | Mono | Yes |
| P14 | 56.8 | 1.8 | 3.9 | 2 | Mono | Yes |
| P15 | 177.7 | 41.7 | 2.1 | 2 | Mono | Yes |
| Min | 5.6 | 0.3 | 0.8 | 0 | ||
| Max | 211.3 | 64.0 | 9.4 | 76 | ||
| 1. Quartile | 14.6 | 4.2 | 1.3 | 2 | ||
| Median | 37.6 | 16.4 | 2.1 | 4 | ||
| 3. Quartile | 124.0 | 35.4 | 3.9 | 15 | ||
MEG recording could not replicate VEEG findings, potentially due to short recording duration.
Fig. 1Boxplot with mean overall delta activity in target source space for healthy controls (group C), seizure-free patients (group SF), and patients with seizures (group P). * p < 0.05, *** p < 0.005.
Delta activity in seizure free patients after epilepsy surgery (group SF). Location of the epileptic focus for determination of overlap with delta activity is based on the consensus decision of epilepsy surgery case conferences, which may deviate from spike locations.
| Patient | Maximum z-value | Mono-/multifocal delta distribution | Overlap of delta with clinical focus |
|---|---|---|---|
| SF1 | 4.5 | Multi | Yes |
| SF2 | 7.2 | Multi | Yes |
| SF3 | 3.0 | Mono | Yes |
| SF4 | 8.8 | Multi | Yes |
| SF5 | 12.9 | Multi | Yes |
| SF6 | 14.7 | Mono | Yes |
| SF7 | 9.3 | Mono | Yes |
| SF8 | 1.7 | Mono | Yes |
| SF9 | 4.7 | Mono | Yes |
| SF10 | 8.0 | Multi | Yes |
| Min | 1.7 | ||
| Max | 14.7 | ||
| 1. Quartile | 4.5 | ||
| Median | 7.6 | ||
| 3. Quartile | 9.3 | ||
Fig. 2Results of iEEG delta activity of patient P13, visualized on the patient's MRI volume. The seizure onset zone is marked by a red circle, interictal areas are marked by a black line.
Fig. 3Preoperative delta activity z-values of patient P13 on post-surgical MRI after second surgery, centered on spike location. The reoperation resected the cyst and surrounding cortex, including the delta maximum and spike localizations. The delta activity findings were not used for planning of the surgical procedure.